New patent for Novo Nordisk drug LEVEMIR PENFILL

   January 31, 2019    Comments Off on New patent for Novo Nordisk drug LEVEMIR PENFILL    Posted in: Patent Added
Annual Drug Patent Expirations for LEVEMIR+PENFILL Levemir Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from four suppliers. There is… The post New patent for Novo Nordisk drug LEVEMIR PENFILL appeared first on DrugPatentWatch - Make Better Decisions.
  

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog